First of many site approvals, including sites in the US, Europe and the Middle East, expected throughout Q1-Q3 2025 Company remains on track for first subject treated in pivotal, adaptive Phase 3 ...

The 80-patient placebo-controlled randomized Phase 2 study will evaluate the efficacy of opaganib in combination with Bayer's darolutamide in men with metastatic castrate-resistant prostate cancer ...

The 80-patient placebo-controlled randomized Phase 2 study will evaluate the efficacy of opaganib in combination with Bayer's darolutamide in men with metastatic castrate-resistant ...

Persistent infection with oncogenic viruses compromises the recognition, activation, and elimination abilities of cytotoxic immune cells, leading to exhaustion, anergy, senescence, activation-induced ...

Recent trends reveal a sharp rise in cancer cases in India, with younger patients and a lack of effective screening programs contributing to late-stag ...

An investigational therapeutic vaccine showed clinical effectiveness in patients with human papillomavirus (HPV)16-positive cervical intraepithelial neoplasia grade 3 (CIN3), according to results from ...

For decades, scientists have tried to stop cancer by disabling the mutated proteins that are found in tumors. But many ...

An oncoprotein can interact with many oncogenic pathways in HPV-induced cancers ... Secondly, in the sera of some people who have previously been infected with HPVs but where the viruses are cleared, ...

Continued exposure to the virus can cause these cells to grow uncontrollably ... About 10% of infections are oncogenic, meaning they can transform normal cells into cancerous ones.

CMAJ Study Highlights Recipe for Healthy AgingA review article published in Canadian Medical Association Journal summarizes ...

Through the SeekInCare test, the genomic features (CNA, FS, end motif, and oncogenic virus) were analyzed by the sWGS data. Additionally, the PTM value from OncoSeek was incorporated as an additional ...